The CONSORT-Path Core Delivery and Advisory groups propose to create an extension to the CONSORT statement to define the minimum reporting of pathology items within a study.
The guideline development process follows the methodology recommended by the EQUATOR network and will consist of the following phases:
- A systematic review of existing guidance relating to the practice of pathology within clinical trials and the creation of a unified item list.
- Consensus modified Delphi process informed by the systematic review unified item list.
- Final consensus meeting. An international group of diverse stakeholders, including clinical trialists of all specialities, regulators, journal editors, industry and patient partners will produce the final elements defining the CONSORT-Path standards. Planned for Spring 2022.
Registered: 4 June 2020
Last updated:
Contact: Dr Tim Kendall; Dr Max Robinson Email: [email protected]; [email protected]